Skip to main content
Top
Published in: Drugs & Aging 9/2012

01-09-2012 | Original Research Article

High Prevalence of Medication Non-Adherence in a Sample of Community-Dwelling Older Adults with Adult Protective Services-Validated Self-Neglect

Authors: Anisha Turner, Ann Hochschild, Jason Burnett, Amber Zulfiqar, Carmel B. Dyer

Published in: Drugs & Aging | Issue 9/2012

Login to get access

Abstract

Background

Medication non-adherence can exacerbate disease severity, leading to impairments that interfere with self-care activities in older adults, and, ultimately, death. Elder self-neglect is the most common report to Adult Protective Services (APS) across the USA and is a significant risk factor for early mortality. These individuals often suffer from multiple comorbid diseases that require careful management, but for various reasons they are unwilling or unable to provide themselves with the self-care resources necessary for maintaining health and safety. No studies have assessed whether medication adherence is associated with elder self-neglect.

Objective

The purpose of this study was to assess and describe medication adherence in this population, as well as evaluate associations between medication adherence and cognitive impairment, depression, physical function, and abilities to perform basic and instrumental activities of daily living (BADLs and IADLs).

Methods

A cross-sectional study of 100 community-dwelling adults 65 years of age and older with APS-substantiated elder self-neglect were assessed. In-home comprehensive geriatric assessments (CGAs) were completed and included medication reviews. Information on each medication, including the amount taken from the date dispensed, was collected and used to determine adherence. The criteria for non-adherence were taking <80 or >110 % of at least one medication. The sample was also split into groups of low adherence (≤29 %), moderate adherence (29–86 %) and high adherence (≥86 %). Scores on the CGA measures Mini-Mental State Examination, Geriatric Depression Scale, Physical Performance Test (PPT) and Kohlman Evaluation of Living Skills were assessed to determine whether cognitive impairment, depression, physical function, and/or ability to perform BADLs and IADLs were associated with non-adherence or low, moderate or high levels of adherence.

Results

Twenty-five per cent of the sample was taking more than seven medications daily. The average rate of adherence was 59 %. Only eight participants (10 %) were adherent to their entire medication regimen, and thus, 90 % were considered non-adherent to at least one medication. The mean number of medications to which individuals were non-adherent was 3.4. The cognitive impairment, depression, physical function and BADL/IADL measures were not statistically associated with medication non-adherence using the cut-points of <80 or >110 %. However, when split into tertiles, the lowest medication adherence level (≤29 %) was significantly associated with a greater number of medications being consumed and lower objective physical function levels as measured by the PPT.

Conclusions

Medication non-adherence is a very prevalent problem among older adults who are self-neglecting, and higher non-adherence levels were associated with the number of medications being consumed as well as lower physical function. Physicians who find high rates of medication non-adherence in their patients should consider barriers to adherence, including a large number of medications, lower physical function and the possibility of elder self-neglect. Future efforts should focus on studying the underlying reasons for medication non-adherence in larger samples of older adults who are self-neglecting. This would facilitate the development of interventions to reduce medication non-adherence in this population.
Literature
1.
go back to reference Sabete E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. Sabete E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
2.
go back to reference Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clinic Proc. 2011;86:304–14.CrossRef Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clinic Proc. 2011;86:304–14.CrossRef
3.
go back to reference Munger M, Van Tassel BW, LaFleur J. Medication nonadherence. MedGenMed. 2007;9:58.PubMed Munger M, Van Tassel BW, LaFleur J. Medication nonadherence. MedGenMed. 2007;9:58.PubMed
4.
go back to reference Schlenk EA, Dunbar-Jacob J, Engberg S. Medication nonadherence among older adults: a review of strategies and interventions for improvement. J Gerontol Nurs. 2004;30:33–43.PubMed Schlenk EA, Dunbar-Jacob J, Engberg S. Medication nonadherence among older adults: a review of strategies and interventions for improvement. J Gerontol Nurs. 2004;30:33–43.PubMed
5.
go back to reference Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging. 2004;21:793–811.PubMedCrossRef Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging. 2004;21:793–811.PubMedCrossRef
6.
go back to reference Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150(4):841–5.PubMedCrossRef Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150(4):841–5.PubMedCrossRef
7.
go back to reference Sullivan S, Kreling D, Hazlet T. Noncompliance with medication regiments and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate. J Res Pharm Econ. 1990;2:19–33. Sullivan S, Kreling D, Hazlet T. Noncompliance with medication regiments and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate. J Res Pharm Econ. 1990;2:19–33.
8.
go back to reference Ferrini A, Ferrini R. Health in the later years. 3rd ed. Boston: McGraw Hill; 2000. Ferrini A, Ferrini R. Health in the later years. 3rd ed. Boston: McGraw Hill; 2000.
9.
go back to reference Centers for Disease Control and Prevention and the Merck Company Foundation. The state of health and aging in America 2004. Whitehouse Station, NJ: The Merck Company Foundation; 2004. Centers for Disease Control and Prevention and the Merck Company Foundation. The state of health and aging in America 2004. Whitehouse Station, NJ: The Merck Company Foundation; 2004.
10.
go back to reference Centers for Disease Control. Healthy aging: preventing disease and improving quality of life among older Americans. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control; 2003. Centers for Disease Control. Healthy aging: preventing disease and improving quality of life among older Americans. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control; 2003.
11.
go back to reference Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA. 2005;294:716–24.PubMedCrossRef Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA. 2005;294:716–24.PubMedCrossRef
12.
go back to reference Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research: a comprehensive review. J Clin Pharm Ther. 2001;26:331–42.PubMedCrossRef Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research: a comprehensive review. J Clin Pharm Ther. 2001;26:331–42.PubMedCrossRef
13.
go back to reference McCarthy R. The price you pay for the drug not taken. Bus Health. 1998;16:27–33.PubMed McCarthy R. The price you pay for the drug not taken. Bus Health. 1998;16:27–33.PubMed
14.
go back to reference Winkler A, Teuscher AU, Mueller B, et al. Monitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Wkly. 2002;132:379–85.PubMed Winkler A, Teuscher AU, Mueller B, et al. Monitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Wkly. 2002;132:379–85.PubMed
15.
go back to reference Baum A, Revenson TA, Singer JE, editors. Handbook of health psychology. Mahwah: Lawrence Erlbaum Associates; 2001. Baum A, Revenson TA, Singer JE, editors. Handbook of health psychology. Mahwah: Lawrence Erlbaum Associates; 2001.
16.
go back to reference Insel K, Morrow D, Brewer B, et al. Executive function, working memory, and medication adherence among older adults. J Gerontol. 2006;61B:102–7. Insel K, Morrow D, Brewer B, et al. Executive function, working memory, and medication adherence among older adults. J Gerontol. 2006;61B:102–7.
17.
go back to reference Salas M, Veld B, van der Linden P, et al. Impaired cognitive function and compliance with antihypertensive drugs in the elderly: the Rotterdam Study. Clin Pharmacol Ther. 2001;70:561–6.PubMedCrossRef Salas M, Veld B, van der Linden P, et al. Impaired cognitive function and compliance with antihypertensive drugs in the elderly: the Rotterdam Study. Clin Pharmacol Ther. 2001;70:561–6.PubMedCrossRef
18.
go back to reference Stilley CS, Bender CM, Dunbar-Jacob J, et al. The impact of cognitive function on medication management: three studies. Health Psychol. 2010;29:50–5.PubMedCrossRef Stilley CS, Bender CM, Dunbar-Jacob J, et al. The impact of cognitive function on medication management: three studies. Health Psychol. 2010;29:50–5.PubMedCrossRef
19.
21.
go back to reference Dong X, Simon M, Mendes de Leon C, et al. Elder self-neglect and abuse and mortality risk in a community-dwelling population. JAMA 2009;302:517–26. Dong X, Simon M, Mendes de Leon C, et al. Elder self-neglect and abuse and mortality risk in a community-dwelling population. JAMA 2009;302:517–26.
22.
go back to reference Lachs MS, Williams CS, O’Brien S, et al. The mortality of elder mistreatment. JAMA. 1998;280:428–32.PubMedCrossRef Lachs MS, Williams CS, O’Brien S, et al. The mortality of elder mistreatment. JAMA. 1998;280:428–32.PubMedCrossRef
23.
go back to reference Dyer CB, Goins AM. The role of interdisciplinary geriatric assessment in addressing self-neglect in the elderly. Generations. 2000;24:23–7. Dyer CB, Goins AM. The role of interdisciplinary geriatric assessment in addressing self-neglect in the elderly. Generations. 2000;24:23–7.
24.
go back to reference Dyer CB, Goodwin JS, Pickens-Pace S, et al. Self-neglect among the elderly: a model based on more than 500 patients seen by a geriatric medicine team. Am J Public Health. 2007;97:1671–6.PubMedCrossRef Dyer CB, Goodwin JS, Pickens-Pace S, et al. Self-neglect among the elderly: a model based on more than 500 patients seen by a geriatric medicine team. Am J Public Health. 2007;97:1671–6.PubMedCrossRef
25.
go back to reference Burnett J, Coverdale JH, Pickens S, et al. What is the association between self-neglect, depressive symptoms and untreated medical conditions? JEAN. 2006;18:25–34. Burnett J, Coverdale JH, Pickens S, et al. What is the association between self-neglect, depressive symptoms and untreated medical conditions? JEAN. 2006;18:25–34.
26.
go back to reference Grocki JH, Huffman KK. Medication adherence among older adults. J Evid Based Soc Work. 2007;4:97–120. Grocki JH, Huffman KK. Medication adherence among older adults. J Evid Based Soc Work. 2007;4:97–120.
27.
go back to reference Lal LS, Hung F, Feng C, et al. Evaluation of medication compliance in patients on antidepressants at an outpatient tertiary cancer setting. J Oncol Pharm Prac. 2011;17:131–5.CrossRef Lal LS, Hung F, Feng C, et al. Evaluation of medication compliance in patients on antidepressants at an outpatient tertiary cancer setting. J Oncol Pharm Prac. 2011;17:131–5.CrossRef
28.
go back to reference Jerant A, Chapman B, Duberstein P, et al. Personality and medication non-adherence among older adults enrolled in a six-year trial. Brit J Health Psych. 2011;16:151–69.CrossRef Jerant A, Chapman B, Duberstein P, et al. Personality and medication non-adherence among older adults enrolled in a six-year trial. Brit J Health Psych. 2011;16:151–69.CrossRef
29.
go back to reference Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227–45.PubMedCrossRef Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227–45.PubMedCrossRef
30.
go back to reference Folstein MF, Folstein S, McHugh PR. Mini-mental state: a practical method of grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975;12:189–98.CrossRef Folstein MF, Folstein S, McHugh PR. Mini-mental state: a practical method of grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975;12:189–98.CrossRef
31.
go back to reference Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. JAGS. 1992;40:922–35. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. JAGS. 1992;40:922–35.
32.
go back to reference Yesavage JA, Brinck TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatric Res. 1983;17:37–9.CrossRef Yesavage JA, Brinck TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatric Res. 1983;17:37–9.CrossRef
33.
go back to reference Almeida OP, Almeida SA. Short versions of the Geriatric Depression Scale: a study of their validity for the diagnosis of major depressive episode according to ICD-10 and DSM-IV. Int J Geriat Psychiatry. 1999;14:858–65.CrossRef Almeida OP, Almeida SA. Short versions of the Geriatric Depression Scale: a study of their validity for the diagnosis of major depressive episode according to ICD-10 and DSM-IV. Int J Geriat Psychiatry. 1999;14:858–65.CrossRef
34.
go back to reference Marc LG, Raue PJ, Bruce ML. Screening performance of the 15-item Geriatric Depression Scale in a diverse elderly home care population. Am J Geriatr Psychiatry. 2008;16:914–21.PubMedCrossRef Marc LG, Raue PJ, Bruce ML. Screening performance of the 15-item Geriatric Depression Scale in a diverse elderly home care population. Am J Geriatr Psychiatry. 2008;16:914–21.PubMedCrossRef
35.
go back to reference Kohlman L. Kohlman evaluation of living skills. 2nd ed. Bethesda: American Occupational Therapy Association; 1992. Kohlman L. Kohlman evaluation of living skills. 2nd ed. Bethesda: American Occupational Therapy Association; 1992.
36.
go back to reference Zimnavoda T, Weinblatt N, Katz N. Validity of the Kohlman Evaluation of Living Skills (KELS) with Israeli elderly individuals living in the community. Occup Ther Int. 2002;9:312–25.PubMedCrossRef Zimnavoda T, Weinblatt N, Katz N. Validity of the Kohlman Evaluation of Living Skills (KELS) with Israeli elderly individuals living in the community. Occup Ther Int. 2002;9:312–25.PubMedCrossRef
37.
go back to reference Reuben DB, Siu AL. An objective measure of physical function of elderly outpatients: the Physical Performance Test. J Am Geriatr Soc. 1990;38:1105–12.PubMed Reuben DB, Siu AL. An objective measure of physical function of elderly outpatients: the Physical Performance Test. J Am Geriatr Soc. 1990;38:1105–12.PubMed
38.
go back to reference Salzman C. Medication compliance in the elderly. J Clin Psychiatry. 1995;56:18–22.PubMed Salzman C. Medication compliance in the elderly. J Clin Psychiatry. 1995;56:18–22.PubMed
39.
go back to reference Spiers MV, Kutzik DM, Lamar M. Variation in medication understanding in the elderly. Am J Health Syst Pharm. 2004;61:373–80.PubMed Spiers MV, Kutzik DM, Lamar M. Variation in medication understanding in the elderly. Am J Health Syst Pharm. 2004;61:373–80.PubMed
40.
go back to reference Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. Clin Epidemiol. 2001;54:S57–60.CrossRef Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. Clin Epidemiol. 2001;54:S57–60.CrossRef
41.
go back to reference Yiannakopoulou E, Papadopulos JS, Cokkinos DV, et al. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil. 2005;12:243–9.PubMedCrossRef Yiannakopoulou E, Papadopulos JS, Cokkinos DV, et al. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil. 2005;12:243–9.PubMedCrossRef
42.
go back to reference Ho PM. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836–41.PubMedCrossRef Ho PM. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836–41.PubMedCrossRef
43.
go back to reference McDonald H, Garq A, Haynes R. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2003;289:2868–79.CrossRef McDonald H, Garq A, Haynes R. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2003;289:2868–79.CrossRef
Metadata
Title
High Prevalence of Medication Non-Adherence in a Sample of Community-Dwelling Older Adults with Adult Protective Services-Validated Self-Neglect
Authors
Anisha Turner
Ann Hochschild
Jason Burnett
Amber Zulfiqar
Carmel B. Dyer
Publication date
01-09-2012
Publisher
Springer International Publishing AG
Published in
Drugs & Aging / Issue 9/2012
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-012-0007-2

Other articles of this Issue 9/2012

Drugs & Aging 9/2012 Go to the issue

Adis Drug Profile

Tadalafil

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.